Enrollment has been the sponsor’s mantra for success in a clinical trial. We should replace it with 4 essential building blocks: selection of the right CRO, identification of study sites, engagement of sites, & enrollment of patients. By @asctherapeutics.

Data scientists from @Merck's Real-World Data Analytics and Innovation team share how they applied the Use-case specific Relevance and Quality Assessment (UReQA) to assess and select high-quality and relevant data for RWE studies.

Increased demand for hybrid and decentralized approaches to clinical trials has increased the use of digital devices & other tools that will make studies more patient centric. @sanofi is leading the way in getting devices into the hands of patients.

Industry and academia alike are experiencing a greater urgency for awareness, education, understanding, and application of #DEI. By Gelise Littlejohn Thomas, JD, MS, @cwru. #clinicaltrials #clinicalresearch.

Forget the perfect patient and find the right patient. Dr. Pandy Opima, director study leader, Early Oncology R&D, at @AstraZeneca, presents ways to truly achieve clinical trial diversity. #clinicaltrials #clinicalresearch #diversity #patientrecruitment.

Two groups that are particularly difficult to recruit for clinical trials are patients of color and those living in remote and rural areas of the country. In those two instances, overcoming recruitment barriers can be challenging.

In January 2023, Janice Chang will take over as the head of @TranscelerateB. Chang has been involved with TransCelerate since it was just a concept and notes the time spent in the group since its launch has been an amazing journey. #ClinicalTrials #DCTs.

Most life sciences execs agree that their companies — even early adopters of AI — still need to make significant changes to leverage AI properly. Here's how to get started (or keep forging ahead). By @PointB. #clinicalresearch #AI #dataanalytics.

There is increased emphasis on evaluating treatment benefits using patient-centric concepts & input from the patient community. Regulators urge sponsors & researchers to engage patients & caregivers to define the disease burden & unmet needs.

Bert Hartog, Jennifer Lee, and Stephen Kemler joined Clinical Leader’s Ed Miseta to share what new technology implementations have and haven’t worked for them. #ClinicalLeaderLive is now available on-demand. Supported by @medrio.

Enrollment has been the sponsor’s mantra for success in a clinical trial. We should replace it with 4 essential building blocks: selection of the right CRO, identification of study sites, engagement of sites, & enrollment of patients. By @asctherapeutics.

As sponsors enable their diverse teams to unleash their creativity in a psychologically and culturally safe environment, they will design protocols, consent forms, and reimbursements adapted to the needs of real-world patient populations.

Data scientists from @Merck's Real-World Data Analytics and Innovation team share how they applied the Use-case specific Relevance and Quality Assessment (UReQA) to assess and select high-quality and relevant data for RWE studies.

Increased demand for hybrid and decentralized approaches to clinical trials has increased the use of digital devices & other tools that will make studies more patient centric. @sanofi is leading the way in getting devices into the hands of patients.

The shifting landscape of industry innovation and unconventional partnerships has created a need for an increased number of PVAs with higher levels of complexity. As a result, many stakeholders face new challenges. By @Roche.

Industry and academia alike are experiencing a greater urgency for awareness, education, understanding, and application of #DEI. By Gelise Littlejohn Thomas, JD, MS, @cwru. #clinicaltrials #clinicalresearch.

There is increased emphasis on evaluating treatment benefits using patient-centric concepts & input from the patient community. Regulators urge sponsors & researchers to engage patients & caregivers to define the disease burden & unmet needs.

Two groups that are particularly difficult to recruit for clinical trials are patients of color and those living in remote and rural areas of the country. In those two instances, overcoming recruitment barriers can be challenging.

In January 2023, Janice Chang will take over as the head of @TranscelerateB. Chang has been involved with TransCelerate since it was just a concept and notes the time spent in the group since its launch has been an amazing journey. #ClinicalTrials #DCTs.

In “Better Than Expected — A Firsthand Experience In #Africa,” Kamila Novak shared her positive impressions from visiting medical research centers in sub-Saharan Africa. However, the picture would not be complete without discussing w whole lot more.